NCT00049257View on ClinicalTrials.gov

Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Prostate Cancer
Interventions
DRUG

carboplatin

Administered Day 1 of each cycle. AUC=6.

DRUG

paclitaxel

administered Days 1, 8, and 15 of each cycle. 100mg/m2

Trial Locations (1)

90095-1781

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT00049257 - Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | Biotech Hunter | Biotech Hunter